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Abstract Werner syndrome (WS) is a rare late-onset
premature ageing disease showing many of the pheno-
types associated with normal ageing, and provides one
of the best models for investigating cellular pathways
that lead to normal ageing. WS is caused by mutation of
WRN, which encodes a multifunctional DNA replication
and repair helicase/exonuclease. To investigate the role
of WRN protein’s unique exonuclease domain, we have
recently identified DmWRNexo, the fly orthologue of
the exonuclease domain of humanWRN. Here, we fully
characterise DmWRNexo exonuclease activity in vitro,
confirming 3′–5′ polarity, demonstrating a requirement
for Mg2+, inhibition by ATP, and an ability to degrade
both single-stranded DNA and duplex DNA substrates
with 3′ or 5′ overhangs, or bubble structures, but with no
activity on blunt ended DNA duplexes. We report a
novel active site mutation that ablates enzyme activity.
Lesional substrates containing uracil are partially
cleaved by DmWRNexo, but the enzyme pauses on
such substrates and is inhibited by abasic sites. These
strong biochemical similarities to human WRN suggest
that Drosophila can provide a valuable experimental
system for analysing the importance of WRN exonucle-
ase in cell and organismal ageing.
Keywords WRN .Werner syndrome . Exonuclease .
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Introduction
Werner syndrome, a rare but highly informative pre-
mature ageing syndrome, is caused by mutation of the
human WRN gene (Yu et al. 1996) which encodes a
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large protein (hWRN) possessing both helicase and
exonuclease activities (Gray et al. 1997; Huang et al.
1998; Shen et al. 1998). WS patients show premature
onset of many signs of normal human ageing including
athero- and arterio-sclerosis and type II diabetes togeth-
er with high cancer incidence (Cox 2008; Epstein et al.
1966; Goto 2001). Genetically, WS patient cells show
karyotypic abnormalities with DNA rearrangements in-
cluding translocations and deletions (Fukuchi et al.
1989; Scappaticci et al. 1982).
The human WRN protein is involved in many
aspects of DNA metabolism including DNA repair
(Bohr 2005), DNA replication (Pichierri et al. 2001;
Rodriguez-Lopez et al. 2002; Sidorova et al. 2008)
and DNA recombination (Saintigny et al. 2002,
reviewed in Cox and Faragher 2007; Kudlow et al.
2007). The exonuclease activity of hWRN has been
implicated in DNA repair using deletion mutants
(Kashino et al. 2005), while single point mutations in
either the exonuclease or helicase domain (or both)
suggest separable but critical roles in recombination
and cell survival (Swanson et al. 2004). The high inci-
dence of stalled replication forks in WS cells
(Rodriguez-Lopez et al. 2002; Sidorova et al. 2008),
together with hypersensitivity of WS cells to 4-
nitroquinoline oxide and camptothecin (Christmann et
al. 2008; Lebel and Leder 1998; Ogburn et al. 1997;
Pichierri et al. 2000; Poot et al. 1999; Prince et al. 1999;
Rodriguez-Lopez et al. 2007), agents that result in
stalled or collapsed replication forks (respectively), sug-
gest that WRN is required either to prevent formation of
hyper-recombinant replication intermediates when
DNA replication is interrupted, or to resolve such struc-
tures when they form.Moreover, the S phase defects and
CPT sensitivity of human WS cells can be overcome by
ectopic expression of a Holliday junction nuclease
(Rodriguez-Lopez et al. 2007). Taken together, these
findings suggest that the WRN exonuclease plays an
important role in maintaining genome stability through
several DNA metabolic pathways.
In vertebrate WRN, one polypeptide contains both
the exonuclease and helicase activities; in other organ-
isms, the two functions are encoded by separate genetic
loci (Plchova et al. 2003). We have recently identified
and cloned theWRN exonuclease orthologue in the fruit
fly Drosophila melanogaster, DmWRNexo (encoded
by the Drosophila gene CG7670, Cox et al. 2007), and
demonstrated genetic instability in hypomorphic
CG7670 mutants (Saunders et al. 2008). For direct
analysis of the exonuclease distinct from helicase activ-
ity, we analysed the activity of purified recombinant
DmWRNexo, which entirely lacks helicase domains,
and showed that the protein does indeed function as an
exonuclease (Boubriak et al. 2009). Here, we provide a
thorough analysis of the enzymatic activities of
DmWRNexo: we assess concentration dependence and
processivity of DNA cleavage by DmWRNexo, its buff-
er and divalent cation specificities, and its cleavage
activity on substrates including DNA bubbles and
duplexes with recessed 5′ or 3′ ends, together with
substrates containing either uracil or an abasic site.
Our results demonstrate that the wild-type enzyme has
low processivity, with an unequivocal 3′–5′ polarity, and
a requirement for Mg2+.We show that a novel active site
mutation (D222V) ablates nuclease activity and investi-
gate how a mutation that alters the surface fold of the
protein (D229V) severely abrogates exonuclease activ-
ity on a range of substrates. We further show that wild-
type DmWRNexo can cleave substrates resembling rep-
lication intermediates, including DNA bubbles and du-
plex overhangs, but that the enzyme pauses on damaged
substrates at uracil and is unable to cleave beyond abasic
sites. The distinct similarities between the exonuclease
activities of hWRN and DmWRNexo that we report
here extend the use of Drosophila as a powerful system
enabling cellular and organismal analysis of the role of
WRN in DNA metabolism, development and ageing.
Materials and methods
DNA substrate preparation
DNA substrates (Table 1, Fig. S1) were annealed at a
3:2 ratio of unlabelled guide strand/labelled oligonu-
cleotide in 1× TE/50 mM NaCl (95°C for 3 min,
cooled to rt) to a final concentration of 250 μM (la-
belled oligonucleotide) and verified by PAGE analysis
(Fig. S1). To make abasic (AP) sites, oligonucleotides
containing a single uracil residue were treated with
uracil DNA glycosylase and substrates prepared as
above. AP sites were confirmed by conversion to
breaks (Higurashi et al. 2003) (Fig. S1).
Bioinformatics and molecular modelling
Protein sequence alignments (DmWRNexo/hWRN
exonuclease domain) utilised BLAST (Altschul et al.
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1990, 1997). A putative active site residue was iden-
tified at aspartate 222, and a D222V mutation was
created by site-directed mutagenesis of CG7670
cDNA using the primers A665T 5′-CGTGAACA
TAAAGAACGTTTTCCGAAAGCTGGCAC-3′ and
A665T-antisense 5 ′-GTGCCAGCTTTCGGAA
AACGTTCTTTATGTTCACG-3′ according to manu-
facturer’s instructions (Quickchange, Stratagene).
Predicted structures of DmWRNexo variants (WT;
D162A, E164A; D222V and D229V) were modelled
against hWRN (Perry et al. 2006) using SWISS-
MODEL (Arnold et al. 2006; Kiefer et al. 2009;
Peitsch et al. 1995) and MacPyMol v 0.99 (Delano
Scientific).
Recombinant protein expression and purification
Mock, WT, mutant D229V, double mutant (D162A,
E164A) (Boubriak et al. 2009) and the new D222V
DmWRNexo proteins were expressed, purified and
analysed by SDS–PAGE and Western blot as de-
scribed previously (Boubriak et al. 2009). Proteins
were stored at −80°C with the addition of 20% glyc-
erol in the storage buffer.
Exonuclease assays
Exonuclease assays were conducted as described pre-
viously (Boubriak et al. 2009). Briefly, purified pro-
teins (12.5–200 nM) were incubated with 2 μM DNA
substrate in WRN exo buffer (hereafter called ‘Exo
buffer’—40 mM Tris–HCl, pH 8.0, 4 mM MgCl2,
5 mM dithiothreitol, 0.1 mg/ml BSA) at 37°C for
30 min (Opresko et al. 2001) unless otherwise stated,
and reactions stopped using 1:1 vol formamide buffer
(80% formamide, 0.5× TBE; Opresko et al. 2001).
Products were resolved and quantified as described
(Boubriak et al. 2009). Competition analysis utilised
Table 1 Oligonucleotides used in this study
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increasing amounts of unlabelled substrate identical in
sequence and structure to the labelled substrate, but
lacking any FLO label.
Cation and ATP assays
EDTA experiments contained Exo buffer with the
addition of EDTA (0–8 mM). Cation substitutions
(default 4 mM; chloride salt) in Exo buffer replaced
MgCl2, as indicated in individual figures. Where rele-
vant, ATP or analogues AMP-PNP or ATPγS were
added to 2 mM. For ATP/magnesium competition,
various concentrations of ATP and MgCl2 were tested
in combination in a standard nuclease assay.
Results
DmWRNexo degrades both ss and ds DNA
in a concentration-dependent manner
To determine optimal molar ratios for analysis of
DmWRNexo cleavage of single-stranded and duplex
DNA substrates in vitro for subsequent experiments,
we assessed the concentration dependence of DNA
cleavage by purified recombinant DmWRNexo using a
fluorescence-based assay we have developed (Boubriak
et al. 2009). Increasing amounts of DmWRNexo protein
(12.5–200 nM) were incubated with two different DNA
substrates: duplex DNA with a 5′ overhang on the
fluorescently labelled reporter strand (5′OV), or single-
stranded (ss) DNA (see Table 1 and Fig. S1a for sub-
strates used). DmWRNexo cleaved both ssFLO and 5′
OV duplex DNA substrates in a concentration-
dependent manner (Fig. 1a, b), with greatest cleavage
achieved at 200 nM protein. The degradation profiles of
both single-stranded and duplex substrates were com-
parable (ss—R200.94, 5′OV—R200.96, see Fig. S2a),
though initial loss of full-length substrate was more
rapid for the duplex than single-stranded DNA.
Interestingly, DmWRNexo proficiently degraded large
amounts of DNA; at molar ratios of 80 times less protein
than DNA, some degree of nuclease activity was ob-
served, though with lower processivity. Based on these
results, DmWRNexo protein concentrations of between
50 and 200 nM were subsequently used.
Relative activity and processivity of WT DmWRNexo
and mutant D229V
We previously reported identification of a mutant of
CG7670 that alters a predicted surface residue aspar-
tate 229 to valine. In flies, this mutation increased
rates of recombination, suggestive that the enzyme
was dysfunctional, which was verified using in vitro
cleavage assays (Boubriak et al. 2009). Here, we have
further investigated the D229V mutant, compared
with wild-type DmWRNexo, by assessing cleavage
of ssDNA substrate over a time course of 14 min. As
shown in Fig. 2a, WT DmWRNexo efficiently degrad-
ed the substrate DNA whilst the D229V mutant
showed a distinct single base clipping which never
proceeded further. Quantification of degradation
(Fig. 2b) allowed a crude estimate of the rate of
activity for both proteins. Since the WT protein
cleaves multiple times in each substrate, the cumula-
tive degradation fitted a logarithmic curve [f(x)00.49
ln(x)+0.11 (R200.92)], whilst the single clipping
Fig. 1 Concentration-dependent DNA cleavage byDmWRNexo.
a Nuclease activity on a 5′-overhang (5′OV) double-stranded 5′-
tailed substrate and b activity on a single-stranded DNA substrate
(ss). Samples were separated on denaturing 14% PAGE.
DmWRNexo protein was used at the following concentrations:
lanes 1, 7012.5 nM, lanes 2, 8025 nM, lanes 3, 9050 nM, lanes
4, 100100 nM, lanes 5, 110200 nM. OO (oligo only, lanes 6, 12)
have no protein added (see Fig. S2a for quantification)
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Fig. 2 Rate of degradation and processivity of DmWRNexo. a
Time course of degradation of single stranded DNA substrate
(2 μM) incubated with 100 nM WT DmWRNexo or D229V
mutant protein at 37°C over a 14-min time course in a total
reaction volume of 80 μl; 5 μl of sample was removed into
formamide dye every minute for analysis on denaturing PAGE.
b Activity was quantified using ImageJ and plotted ±SEM (n03
for WT, n02 for D229V). Best-fit regression for each is shown
(dotted lines—see text for R2 values)—note linear regression for
D229V compared with logarithmic curve for WT DmWRNexo.
c Processivity on addition of unlabelled competitor substrate
(arrows). Upper panel: denaturing PAGE of degradation
products±competitor DNA (10× C010-fold excess competitor
DNA; 25× C025× excess competitor DNA) compared with
control without competitor (WT only). Lower panel: ImageJ
quantification of degradation at 1, 4 and 8 min. x axis represents
position migrated down the gel, y axis shows DNA fluorescence
intensity (area under the curve). Dotted lines indicate relative gel
position normalised to account for gel ‘smile’. Shaded regions
represent degradation occurring after competitor was added, or
equivalent time in ‘WTonly’ control. d Coomassie blue staining
of WT and D229V DmWRNexo following purification and
separation on SDS–PAGE
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activity of the D229V mutant fitted a linear regression
[f(x)00.03x00.08 (R200.96)]. This suggested that
wild-type DmWRNexo has some, albeit limited, proc-
essivity, whilst the D229V mutant is totally non-
processive.
Exonuclease processivity was further investigated
using a competition assay with a non-labelled oligo-
nucleotide otherwise identical to the ssFLO substrate
(Table 1). The addition of 10-fold excess unlabelled
competitor resulted in marked abrogation of cleavage,
while addition of a 25-fold excess of competitor DNA
immediately halted degradation of labelled template
(Fig. 2c), suggesting that WT DmWRNexo readily
dissociates from its substrate and hence has low proc-
essivity on a single-stranded template. It is possible
that the enzyme must reposition itself on the substrate
after each cleavage event.
Human WRN exonuclease is reported to have poor
processivity that is enhanced by multimerisation
(Perry et al. 2010). We therefore investigated the abil-
ity of purified recombinant DmWRNexo to form
oligomers. In gel filtration analysis, DmWRNexo elut-
ed in several peaks consistent with monomer, trimer
and large aggregates (data not shown). Coomassie
staining of the purified proteins on SDS–PAGE
showed the rapid formation in vitro of multimers of
WT DmWRNexo that were stable on heating and
under reducing conditions; such higher molecular
weight bands were not detected for D229V (Fig. 2d).
Hence, low processivity of WT DmWRNexo is not a
consequence of failure of oligomerisation in vitro,
though it is conceivable that the inability of the
D229V mutant to cleave beyond one nucleotide on a
single-stranded substrate may be due to a problem in
forming correct protein–protein interactions due to its
surface alteration (see Fig. S3c).
DmWRNexo recapitulates the 3′–5′ activity of human
WRN
Human WRN has 3′–5′ polarity as an exonuclease
(Shen et al. 1998). Our preliminary studies with
DmWRNexo suggested the same polarity, since a lad-
der of products was observed with 5′ labelling of a
reporter strand (Boubriak et al. 2009). To unequivo-
cally determine nuclease polarity, we compared cleav-
age of the standard 5′ overhang duplex substrate
labelled on the 5′ end of the reporter strand (5′OV)
with a 5′-tailed duplex substrate constructed with the
fluorescein label conjugated to the 3′ recessed end [5′
OV(3′FL), Fig. 3]. As expected, DmWRNexo degrad-
ed the 5′ end-labelled duplex substrate efficiently over
40 min, giving rise to a ladder of labelled products of
decreasing size, indicating progressive cleavage from
the 3′ end of the reporter strand (Fig. 3, lanes 1–5).
Hence, activity consistent with a 3′–5′ exonuclease is
observed.
A bona fide 3′–5′ exonuclease would be expected
to clip off the fluorescein-labelled nucleotide of the 3′-
labelled substrate, resulting in a single nucleotide
product with high mobility in gel electrophoresis.
Within 10 min of incubation of the 3′-labelled sub-
strate with DmWRNexo nuclease, a band at the bot-
tom of the gel representing a single nucleotide was
observed, which increased in intensity with time,
though no intermediate sized fragments were detected
above background (Fig. 3, lanes 9–13). This 3′ single
nucleotide clipping confirms that DmWRNexo is in-
deed a 3′–5′ exonuclease.
Quantification of full-length substrate remaining
(Fig. S2b) shows that the majority was degraded
when 5′ end-labelled, while only 40% of the 3′
end-labelled substrate was cleaved. This suggests
Fig. 3 Exonuclease polarity of DmWRNexo. Time course of
nuclease activity of WT DmWRNexo and the D229V mutant
protein on 5′-labelled (5′ overhang substrate labelled with fluo-
rescein at the 5′ end—5′OV) or 3′-labelled substrate [fluorescein
on the recessed 3′ nucleotide (5′OV (3′FL)]. (See Fig. S2b for
quantification)
798 AGE (2013) 35:793–806
that the fluorescein label may partially inhibit nu-
clease digestion by DmWRNexo, possibly because
of steric hindrance (this is not observed for bacte-
riophage λ exonuclease, see Fig. S4). Most impor-
tantly, DmWRNexo exhibits 3′–5′ polarity with no
evidence of any 5′–3′ activity.
These templates allowed further analysis of the
D229V mutant protein. Over a 30-min time course,
this mutant protein demonstrated limited degradation
of the 5′-labelled duplex overhang substrate (Fig. 3,
lanes 6–8), consistent with our previous observations,
but unlike WT, the mutant enzyme showed no clipping
of a 3′ end-labelled substrate (Fig. 3, lanes 14–16),
suggesting that the fluorescein moiety does block the
229 mutant.
DmWRNexo can use Mn2+ and Mg2+ as divalent
cation
Human WRN exonuclease requires two divalent metal
ions to be coordinated by acidic residues within the
active site (Perry et al. 2006); such residues are con-
served in DmWRNexo (Fig. S3a). We verified that the
standard buffer used (WRN exo buffer) was also opti-
mal for DmWRNexo nuclease activity (Fig. S5), and it
was therefore used to test the cation requirements for
nuclease activity ofWTand D229V DmWRNexo in the
presence of magnesium, manganese, calcium or zinc, on
both ss and 5′OV substrates (Fig. 4a, upper and lower
panels, respectively). Both WT DmWRNexo and the
D229V mutant were found to show a specific require-
ment for Mg2+ (Fig. 4a, lanes 2 and 3), with no activity
seen for either protein with any of the other cations at
4 mM on either ss or duplex substrates (Fig. 4a, lanes 4–
12 inclusive). Since WRNexo from Arabidopsis can
utilise cation concentrations as low as 100 μM
(Plchova et al. 2003), we tested the cleavage activity
of DmWRNexo with 100 μM Mg2+ or Mn2+.
Intriguingly, manganese at this lower concentration did
support exonuclease activity of DmWRNexo (Fig. 4b,
lanes 3 and 13), with a similar degree of cleavage
detected as with the same low concentration of Mg2+
(Fig. 4b, lane 10). Partial inhibition of cleavage was
detected when Mn2+ (100 μM or 4 mM) or Ca2+
(100 μM) were added in the presence of 4 mM Mg2+
(Fig. 4b, lanes 6, 8, 12, and 15) suggesting some form of
cation competition for the enzyme active site or perhaps
suboptimal cleavage in a ‘hetero-cation’ state. By con-
trast, zinc totally blocked enzyme activity, perhaps by
outcompeting Mg2+ (Fig. 4b, compare lanes 2 and 7).
Therefore, DmWRNexo cleaves DNA preferentially us-
ing Mg2+ even at low levels, with higher amounts per-
mitting greater nuclease activity.
Further, there is an absolute requirement for cations
for DmWRNexo, as no substrate cleavage was
detected without metal ions present (Fig. 4b, lanes 1
and 9). Consistent with this, the stimulation of nucle-
ase activity by 4 mM Mg2+ was abrogated by addition
of the chelating agent EDTA in a concentration-
dependent manner: as increasing amounts of EDTA
sequestered the cation, there was loss of activity
(Fig. 4c), with single-stranded DNA cleavage
inhibited at 2 mM EDTA (Fig. 4c, upper panel) and
duplex cleavage markedly blocked at 4 mM EDTA
(Fig. 4c, lower panel). Note that at a 1:1 molar ratio of
cation/chelator (Fig. 4c, lane 5), nearly all nuclease
activity was lost.
ATP inhibits DmWRNexo
A physiological chelator of Mg2+ in cells is ATP,
suggesting that ATP concentrations might impact on
nuclease activity. Others have assessed human WRN
exonuclease activity in the presence of 1 mM ATP,
as this is required for the helicase activity intrinsic to
hWRN (Shen et al. 1998). We therefore varied both
ATP and Mg2+ concentrations from 100 μM to
8 mM; nuclease activity was assessed in terms of
amount of product degraded and degree of degrada-
tion according to the schematic shown (Fig. 5a). As
expected, in the absence of Mg2+, no cleavage was
detected, while 100 μM Mg2+ supported good activ-
ity in the absence of ATP that was inhibited by
increasing ATP concentrations. Greatest nuclease ac-
tivity was observed at 1 mM Mg2+ in the absence of
ATP (Fig. 5a). When ATP was added, more Mg2+
was required in the reaction, consistent with ATP
sequestration of the cation; higher concentrations of
ATP abrogated nuclease activity even at high cation
concentrations, with an effective loss of activity at
an ATP/Mg2+ molar ratio of between 1:1 and 2:1 for
any concentration (Fig. 5a). This suggests that the
ATP/Mg2+ ratio in an exonuclease buffer (and in the
cell) is important for optimal activity. Note that the
ATP/Mg2+ ratio in the WRN Exo/helicase buffer is
1:2 (Opresko et al. 2001) and so can effectively
support both helicase and exonuclease activities of
the human WRN protein.
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DmWRNexo does not require ATP hydrolysis
to cleave DNA and lacks helicase activity
While our data strongly suggest that DmWRNexo
does not require ATP (and has no helicase activity
requiring it) but instead is inhibited by ATP (Fig. 5a
and Fig. S6, lane 4), it has been reported elsewhere
that hWRN exonuclease needs ATP to function
(Machwe et al. 2006). To formally test the possibility
that DmWRNexo requires ATP hydrolysis to act, we
compared exonuclease function of both WT
DmWRNexo and the attenuated D229V mutant on a
Fig. 4 DmWRNexo prefer-
entially requires magnesium
for catalysis. a Nuclease
activity on single-stranded
substrate (SS, upper panel)
or duplex overhang (5′OV,
lower panel) of WT or
mutant D229V (229)
DmWRNexo protein (or no
protein ‘−’, lanes 1, 4, 7 and
10) with 4 mM either Mg2+,
Zn2+, Ca2+ or Mn2+. b
DmWRNexo incubated with
ss DNA and cations as indi-
cated, with or without Mg2+.
c DmWRNexo incubated
with ss (SS, upper panel) or
duplex (5′OV, lower panel)
DNA substrate with
4 mM Mg2+ and increasing
amounts of EDTA. In all
cases, products were ana-
lyzed on 14% denaturing
PAGE
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single-stranded DNA substrate in the presence and
absence of 2 mM ATP, AMP-PNP or ATPγS (non-
or poorly-hydrolysable ATP analogues) with
4 mM Mg2+ (to avoid chelation of essential Mg2+).
We did not detect any statistically significant differ-
ences in DmWRNexo nuclease activity between sam-
ples containing the various ATP analogues compared
with controls lacking ATP (Fig. 5b).
A novel active site mutant D222V lacks exonuclease
activity
To further explore critical catalytic residues of
DmWRNexo, we generated a novel mutation of aspar-
tate 222 to valine, as this is predicted to lie also within
the active site of the enzyme by comparison with
hWRN exonuclease (see Fig. S3). The mutant
D222V protein was expressed and purified to near-
homogeneity (Fig. S7a, b) for functional testing in
vitro in comparison with purified recombinant wild-
type DmWRNexo. As predicted, DmWRNexo D222V
lacked any exonuclease activity on either single-
stranded DNA (Fig. S7c) or a 5′ overhang duplex
substrate (data not shown), while further assessment
of cleavage at different temperatures over an extended
time course and in the presence of various cations
detected no activity (Fig. S7c, d), suggesting that
D222 is indeed a conserved co-ordinate catalytic
residue.
To rule out the possibility that the desalting step was
responsible for loss of enzyme activity of D222V, WT
DmWRNexo, D222Vor mock (negative control) imid-
azole eluates from His-Trap columns were tested direct-
ly in a standard nuclease reaction without desalting.
Remarkably, wild-typeDmWRNexowas exonucleolyti-
cally active even at 405 mM imidazole (Fig. S7e, f),
suggesting it is a very robust enzyme with little sensi-
tivity to salt; however, no activity was detected for
D222V at any imidazole concentration tested. Hence,
the mutant enzyme is likely to be inactive through loss
of a critical aspartate in the active site, rather than
through artefacts of enzyme preparation.
DmWRNexo is active on alternative DNA structures
including bubbles and recessed duplexes
Werner syndrome cells lacking functional WRN spe-
cifically show a defect in processing stalled replication
forks (Rodriguez-Lopez et al. 2002; Sidorova et al.
2008). We therefore tested the ability of DmWRNexo
to cleave substrates that might exist at sites of stalled
or aborted DNA replication sites, or intermediates
Fig. 5 Inhibition of
DmWRNexo nuclease
activity by ATP. a Nuclease
activity of 50 nM WT
DmWRNexo on ss DNA
with Mg2+ and/or ATP were
scored as good, partial or
none, as shown in the
scheme on the right (n02).
b 100 nM WT or D229V
(229) DmWRNexo were
tested on ss DNA substrate
with 2 mM ATP, ATPγS,
AMP-PNP or no ATP.
Quantification of degrada-
tion assayed on denaturing
gels used ImageJ as before
(n03, ±SEM). (Note that
removal of even a single
nucleotide by D229V repre-
sents degradation of full-
length substrate)
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formed during processing of such sites. A range of
mutants was assessed in comparison to wt
DmWRNexo, including the novel D222V mutant,
D229V surface mutation, and a double active site
mutant ‘DE’ (Boubriak et al. 2009).
We found that DmWRNexo cannot cleave blunt
ended duplex DNA (Fig. 6a). By contrast, extensive
cleavage of a blunt-ended bubble substrate with an
internal 20 nucleotide mismatched region was
detected for the WT protein (Fig. 6b). These results
together suggest that DmWRNexo requires ss DNA
for loading, but it does not need a free single-stranded
end.
Substrates with both a ‘double overhang’ (DO,
Fig. 6c) and a ‘double underhang’ (DU, Fig. 6d) are
equally well degraded by WT DmWRNexo, again
supporting the assertion that single-stranded DNA is
necessary for loading. Notably, the D229V mutant
enzyme can cleave double overhang but not the dou-
ble underhang substrates (compare lanes 8 in Fig. 6c
and d), supporting the idea that the 5′-labelled strand
acts to load the enzyme on the DU substrates and that
the unlabelled strand is degraded first. Note that the
D229V protein is probably blocked by fluorescein (see
Fig. 3 and Fig. S2b), which may prevent its cleavage
of the DU substrate. D229V also cannot degrade bub-
ble substrates (Fig. 6b, lane 8) and may lack the
structural flexibility necessary to bind onto con-
strained ss DNA.
Activity of DmWRNexo on lesional templates
WRN is implicated in base excision DNA repair
(BER) (Bohr 2005; Harrigan et al. 2003, 2006), a
process required to repair damage to individual bases,
including removal of uracil from DNA. Thus, we
tested cleavage of substrates containing a single uracil
in the guide strand either external or internal to the
duplex region (see Table 1 and Fig. 7). BER removes
uracil using DNA glycosylase (UDG) resulting in an
abasic site: we therefore mimicked this process by
treating oligonucleotides containing uracil with UDG
prior to annealing. Substrate integrity was verified on
denaturing PAGE (Fig. S1b). Efficiency of conversion
of uracil to AP sites by UDG was determined by
treatment with potassium hydroxide to break DNA at
AP sites, followed by analysis on ethidium bromide
PAGE (Fig. S1c); virtually all the UDG-treated sub-
strates were cleaved upon exposure to alkali. External
AP sites proved extremely fragile and fragmented
prior to use so were not employed.
As expected, WT DmWRNexo efficiently cleaved a
5′-labelled 5′ overhang substrate (5′OV, Fig. 7, lanes 1–6)
compared to lesion-containing 5′OV substrates. Note that
this cleavage is very efficient because high concentrations
of enzyme (200 nM) were employed in these assays.
While the internal uracil substrate was subject to some
degradation, specific pause sites were detected such that
even after 40-min incubation with high concentrations of
enzyme, degradation did not proceed to completion
(Fig. 7, lanes 8–12). This pausing was even more marked
when the uracil was placed external to the duplex region
in a positionwhere presumably the enzyme binds initially
to the single-stranded overhang. The position of pause
Fig. 6 Cleavage of replication bubble and fork-like structures
by DmWRNexo. Nuclease activity of 200 nM DmWRNexo
[WT, the D222V (222), D162A E164A (DE) or D229V (229)
mutants] or mock (M) negative control on 5′-labelled substrates:
a blunt duplex (BD), b bubble substrate, c double overhang
relative to the labelled strand (DO) and d double underhang
relative to the labelled strand (DU). Products of nuclease activ-
ity were analysed on 14% denaturing PAGE after 30 min (left
panels) or 45 min (right panels). (Note that WT DmWRNexo is
an internal comparator in all assays)
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sites correlated broadly with the position of the uracil.
Interestingly, a single internal abasic site gave rise to the
same initial pause sites as observed with internal uracil in
the same position (compare Fig. 7, lanes 20 and 9), but a
stop, rather than pause, site was subsequently encoun-
tered, resulting in DNAproducts of the same size as those
observed with external uracil in the single-stranded re-
gion (compare Fig. 7, lanes 22 and 23 with lanes 17 and
18). Taken together, these data strongly suggest that
DmWRNexo is incapable of degrading substrates that
contain abasic sites and is severely inhibited by the
presence of uracil, even though the lesion is in the guide
strand and not in the degraded strand.
Discussion
In this paper, we examine in detail the enzymology of
the Drosophila orthologue of hWRN exonuclease,
DmWRNexo. The ability of DmWRNexo to cleave
single-stranded DNA with the high efficiency that we
observe here is fully consistent with reports showing
that hWRN exo degrades ssDNA in a length-
dependent manner (Machwe et al. 2006; Xue et al.
2002). (Previous suggestions that hWRN is unable to
cleave single-stranded DNA were based on substrates
much shorter than the 50-mer oligonucleotide used
here.) Given the probable roles of WRN exonuclease
in end processing (Perry et al. 2006) during either
classical DNA repair or in processing defective repli-
cation forks (e.g. Machwe et al. 2007; Rodriguez-
Lopez et al. 2002, 2007; Sidorova et al. 2008), activity
on ss DNA may be required. Notably, the RecQ family
member human BLM, which is highly related to
hWRN, can translocate along ssDNA (Gyimesi et al.
2010)—perhaps human WRN similarly translocates
via its helicase activity but also can cleave through
ss exonuclease activity.
Here, we clearly demonstrate that DmWRNexo,
like hWRN exonuclease, is a 3′–5′ exonuclease.
Furthermore, the enzyme is dependent upon Mg2+
(or low levels of Mn2+) for activity and has no require-
ment for ATP. Published hWRN crystal structures of
the active site show identical spacing of 3.7 Å between
the two metal ions, whether Mg2+ or Mn2+ (Perry et al.
2006); moreover, WRNexo from Arabidopsis can also
utilize Mg2+ or Mn2+ (Plchova et al. 2003).
DmWRNexo acts with 3′–5′ polarity since it progres-
sively degrades 5′-labelled substrates to produce a
ladder of products of decreasing size, while a 3′ label
is immediately cleaved (see Fig. 3). These findings are
incompatible with any 5′–3′ exonuclease activity. The
3′ fluorescein label might be anticipated to interfere
with exonuclease cleavage since hWRN exonuclease
does not cleave blocked 3′ ends bearing 3′ phosphate,
3′ phosphoglycolates or 3′ tyrosyl residues (Harrigan
et al. 2007). However, DmWRNexo showed good
activity on the 3′-labelled substrate, removing the 3′
FLO label from approximately 40% of the full-length
substrate. Therefore, it is highly unlikely that fluores-
cein is specifically blocking a putative 5′–3′ activity,
although it should be noted that while 40% of 3′-
labelled substrate is degraded, around 80% of 5′-la-
belled substrate is cleaved under identical conditions,
so the configuration of fluorescein presentation does
impact to some extent on degradation. Taken together,
our results here demonstrate that DmWRNexo is a
bona fide 3′–5′ exonuclease.
Fig. 7 Inhibition of cleavage
by uracil and abasic sites. The
ability of DmWRNexo to
degrade past a lesion was
tested using 5′OV duplex
substrate with a single uracil
in the substrate tail (Ext-U) or
an internal uracil or abasic
site a short way into the
duplex (Int-U or IntAP,
respectively). Activity of WT
DmWRNexo (200 nM) at
37°C for 0–40 min on 2 μM
substrate is shown, with
products analysed on 14%
denaturing PAGE
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The single nucleotide clipping by the D229Venzyme
implies that once this mutant enzyme binds to substrate
and cleaves off a single nucleotide, it remains bound to
that substrate and cannot dissociate—if it could, then we
would expect sequential binding, cleavage and dissoci-
ation resulting in progressive degradation of the sub-
strate with time, though probably with slower kinetics
than WT since the binding step rather than nucleotide
hydrolysis is likely to be rate limiting. The mutation of a
surface aspartate to valine in the D229V mutant may
result in overall loss of protein stability, failure of oligo-
merisation or, more subtly, affect association of DNA
with the enzyme, particularly if D229 acts as a guide
residue to channel DNA to be degraded into the
enzyme’s active site. Since D229 has some limited
activity on duplex DNA, positioning of the non-
degraded strand may allow processive repositioning of
the enzyme whereas the lack of this guide strand on
ssDNA substrates may cause blockage or non-reversible
binding. The inability of this mutant protein to cleave
substrates bearing a 3′ FLO is particularly interesting in
this context; perhaps the D229Vmutant lacks flexibility
to accommodate the fluorescein group, or the path of
DNA through the protein is altered.
Like hWRN exonuclease, DmWRNexo is inactive
on duplex substrates with blunt ends, but is able to
cleave bubble substrates. The human WRN enzyme
requires ATP for activity on such substrates (Shen and
Loeb 2000), though this is probably to support the
helicase action in providing a suitable template for
degradation by the nuclease activity. By contrast, we
show that DmWRNexo does not require ATP for DNA
degradation, but neither does it possess any ATP-
dependent helicase domains, so a lack of ATP require-
ment is not unexpected. It is theoretically possible that
cleavage of bubble substrates by DmWRNexo may
involve a cryptic endonuclease activity, as has been
suggested for hWRN (Xue et al. 2002). However, as
we have seen no other evidence for endonuclease
activity in this study, and DmWRNexo has activity
on ssDNA, it is more likely that cleavage of bubbles
by DmWRNexo results from the protein binding to
ssDNA within the unpaired region of the bubble sub-
strate. Intriguingly, the D229V variant is inactive on
DNA bubbles or double underhang substrates. Such
limited activity correlates with elevated levels of
mitotic exchange in CG7670e04496/CG7670D229V flies
(Boubriak et al. 2009) and is fully consistent with an
inability of the D229V mutant protein to bind to stalled
fork substrates, which would result in the generation of
double strand breaks, and their subsequent repair by
cross-over pathways of homologous recombination.
hWRN exonuclease is inhibited by various oxidative
lesions in either strand of a synthetic duplex (Bukowy et
al. 2008; Harrigan et al. 2007) with around 50–70%
decrease in activity, although hWRN helicase can un-
wind long-patch BER substrates (Harrigan et al. 2003)
and is known to participate in BER downstream of the
initial processing events (Harrigan et al. 2003, 2006).
We show that DmWRNexo also degrades duplex sub-
strates containing uracil in the guide strand, with a
similar inhibition or ‘pausing’ at the lesions (while the
pause site is strong, there is evidence of cleavage past
the uracil site since smaller DNA products are detected
below the major ‘pause’ band). A single abasic site
instead inhibits any further substrate cleavage, possibly
resulting in dissociation of the enzyme from its sub-
strate. In humans, Ku stimulation overcomes this inhi-
bition (Bukowy et al. 2008), suggesting that any role of
DmWRNexo in BER may require co-operation with a
WRN-like helicase and Ku orthologues, and is likely to
be downstream of abasic-site processing.
The progeroid human Werner syndrome presents a
useful model system to study the biology of ageing by
investigating the role(s) of the proteinWRN, the function
of which is lost in WS. Despite such usefulness, human
WS suffers from serious experimental limitations, par-
ticularly in the rarity and genetic heterogeneity of patient
material, the inability to study the impact of chosen
mutations on organismal phenotype and the confounding
variable of the helicase co-existing on the same polypep-
tide as the nuclease (mutations may therefore have a
dominant negative effect, e.g. Crabbe et al. 2004). To
overcome these limitations, we are developing a Werner
syndrome fly model. We have identified the Drosophila
orthologue of human WRN exonuclease (Cox et al.
2007), hypomorphic mutation of which results in WS-
like phenotypes including hypersensitivity to CPT and
extremely high rates of recombination (Saunders et al.
2008), and shown that the protein does indeed possess
exonuclease activity (Boubriak et al. 2009). Here, we
have analysed the activity of this exonuclease,
DmWRNexo. Our demonstration of 3′–5′ directionality,
requirement for Mg2+, activity on replication-like sub-
strates and inhibition by uracil and abasic sites show that
DmWRNexo is enzymatically very similar to its human
orthologue. We have additionally explored the impact
both of active site mutations (essentially null) and of a
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more subtle alteration impacting on surface fold, that
nevertheless has a marked negative effect on enzyme
processivity and ability to cleave both ss DNA and
replication-type substrates, particularly DNA bubbles.
Such characteristics of DmWRNexo therefore provide
strong validation of the fly model of WS and allow
effects on the organism to be interpreted within the
context of a clear biochemical understanding of the
activity of the WRN nuclease.
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